United States Ophthalmic Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

1.  Report Overview

1.1.  Report Description

1.2.  Research Methods

1.3.  Research Approaches

2.  Executive Summary

3.  Market Overview

3.1.  Introduction

3.2.  Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.4.  Challenges

3.3.  PEST-Analysis

3.4.  Porter's Diamond Model for the United States Ophthalmic Drugs Market

3.5.  IGR-Growth Matrix Analysis

3.6.  Value Chain Analysis of the United States Ophthalmic Drugs Market

3.7.  Competitive Landscape in the United States Ophthalmic Drugs Market

4.  The United States Ophthalmic Drugs Market by Drug Class

4.1.  Anti-allergy

4.2.  Anti-inflammatory

4.3.  Non-steroidal Drugs

4.4.  Steroidal Drugs

4.5.  Anti-VEGF Agents

4.6.  Anti-glaucoma

4.7.  Others

5.  The United States Ophthalmic Drugs Market by Disease Type

5.1.  Allergies

5.2.  Infection

5.3.  Glaucoma

5.4.  Retinal Disorders

5.5.  Uveitis

5.6.  Dry Eye

5.7.  Others

6.  The United States Ophthalmic Drugs Market by Product Type

6.1.  Prescription Drugs

6.2.  Over-the-counter-drugs

7.  The United States Ophthalmic Drugs Market by Dosage Form

7.1.  Eye Solutions & Suspensions

7.2.  Gels

7.3.  Capsules & Tablets

7.4.  Eye Drops

7.5.  Ointments

8.  The United States Ophthalmic Drugs Market by Route of Administration

8.1.  Systematic

8.2.  Topical

8.3.  Local Ocular

9.  The United States Ophthalmic Drugs Market by Drug Type

9.1.  Branded Drugs

9.2.  Generic Drugs

10.  Company Profiles

10.1.  Company 1

10.2.  Company 2

10.3.  Company 3

10.4.  Company 4

10.5.  Company 5